8-(3-(<em>R</em>)-aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydropurine-2,6-dione (BI 1356), a highly potent, selective, long-acting, and orally bioavailable DPP-4 inhibitor for the treatment of type 2 diabetes

Matthias Eckhardt, Frank Himmelsbach, Michael Mark et al.|DORA PSI (Paul Scherrer Institute)|2007

Cited by 0